Top Manufacturing Stocks To Research – May 20th

D-Wave Quantum, Pfizer, and Taiwan Semiconductor Manufacturing are the three Manufacturing stocks to watch today, according to MarketBeat’s stock screener tool. Manufacturing stocks are the inventories of raw materials, work-in-progress items and finished goods that a manufacturing company holds for its production process. They appear as current assets on the balance sheet and represent materials at various stages of completion. Effective management of these stocks helps minimize carrying costs, prevent stockouts and ensure uninterrupted production. These companies had the highest dollar trading volume of any Manufacturing stocks within the last several days.

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

QBTS stock traded up $4.18 during mid-day trading on Tuesday, reaching $17.33. The company’s stock had a trading volume of 236,987,611 shares, compared to its average volume of 39,446,001. D-Wave Quantum has a fifty-two week low of $0.75 and a fifty-two week high of $17.56. The stock has a market cap of $5.05 billion, a PE ratio of -41.40 and a beta of 0.90. The company’s 50 day moving average is $8.15 and its two-hundred day moving average is $6.28.

Read Our Latest Research Report on QBTS

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

NYSE:PFE traded up $0.37 on Tuesday, hitting $23.37. The stock had a trading volume of 35,931,357 shares, compared to its average volume of 40,872,571. The stock has a market cap of $132.84 billion, a price-to-earnings ratio of 16.59, a PEG ratio of 0.64 and a beta of 0.58. Pfizer has a 1-year low of $20.92 and a 1-year high of $31.54. The company has a quick ratio of 0.73, a current ratio of 1.00 and a debt-to-equity ratio of 0.63. The company has a fifty day moving average price of $23.60 and a two-hundred day moving average price of $25.28.

Read Our Latest Research Report on PFE

Taiwan Semiconductor Manufacturing (TSM)

Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides a range of wafer fabrication processes, including processes to manufacture complementary metal- oxide-semiconductor (CMOS) logic, mixed-signal, radio frequency, embedded memory, bipolar CMOS mixed-signal, and others.

NYSE:TSM traded down $1.13 on Tuesday, reaching $192.37. The company’s stock had a trading volume of 3,462,750 shares, compared to its average volume of 15,869,292. Taiwan Semiconductor Manufacturing has a 12-month low of $133.57 and a 12-month high of $226.40. The stock has a 50 day moving average price of $167.75 and a 200 day moving average price of $187.38. The firm has a market cap of $997.71 billion, a price-to-earnings ratio of 27.33, a price-to-earnings-growth ratio of 0.66 and a beta of 1.21. The company has a quick ratio of 2.30, a current ratio of 2.57 and a debt-to-equity ratio of 0.24.

Read Our Latest Research Report on TSM

Further Reading